BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32269723)

  • 21. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
    Shi H; Chai P; Jia R; Fan X
    Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA methylations in human cancers.
    Han X; Wang M; Zhao YL; Yang Y; Yang YG
    Semin Cancer Biol; 2021 Oct; 75():97-115. PubMed ID: 33220459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas.
    Xu S; Tang L; Dai G; Luo C; Liu Z
    Front Cell Dev Biol; 2020; 8():594112. PubMed ID: 33240891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of m5C Modifications in RNA Sequences by Combining Multiple Sequence Features.
    Dou L; Li X; Ding H; Xu L; Xiang H
    Mol Ther Nucleic Acids; 2020 Sep; 21():332-342. PubMed ID: 32645685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m
    Yi L; Wu G; Guo L; Zou X; Huang P
    Mol Ther Nucleic Acids; 2020 Sep; 21():299-314. PubMed ID: 32622331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6.
    Selmi T; Hussain S; Dietmann S; Heiß M; Borland K; Flad S; Carter JM; Dennison R; Huang YL; Kellner S; Bornelöv S; Frye M
    Nucleic Acids Res; 2021 Jan; 49(2):1006-1022. PubMed ID: 33330931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic characteristics of m
    Li X; Meng Y
    J Cell Mol Med; 2021 Feb; 25(3):1383-1393. PubMed ID: 33400376
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Wang J; Li Y; Xu B; Dong J; Zhao H; Zhao D; Wu Y
    Onco Targets Ther; 2021; 14():145-155. PubMed ID: 33447056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
    Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
    Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of RNA modifications in cancer.
    Barbieri I; Kouzarides T
    Nat Rev Cancer; 2020 Jun; 20(6):303-322. PubMed ID: 32300195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma.
    Shi Q; Xue C; Yuan X; He Y; Yu Z
    Sci Rep; 2020 Sep; 10(1):15083. PubMed ID: 32934298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. m
    Xiang S; Ma Y; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Ji H; Zheng Y; Li X; Li J; Wen Q; Xiao Z
    Front Mol Biosci; 2020; 7():599340. PubMed ID: 33365328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pan-cancer analysis reveals genetic alterations, molecular mechanisms, and clinical relevance of m
    Du E; Li J; Sheng F; Li S; Zhu J; Xu Y; Zhang Z
    Clin Transl Med; 2020 Sep; 10(5):e180. PubMed ID: 32997404
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
    Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
    Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-lncRNA Immune Prognostic Signature for Cervical Cancer.
    Chen Q; Hu L; Huang D; Chen K; Qiu X; Qiu B
    Front Genet; 2020; 11():533628. PubMed ID: 33173530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epitranscriptome beyond m
    Wiener D; Schwartz S
    Nat Rev Genet; 2021 Feb; 22(2):119-131. PubMed ID: 33188361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
    Zhang B; Tang B; Gao J; Li J; Kong L; Qin L
    J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation.
    Gao J; Zhang HP; Sun YH; Guo WZ; Li J; Tang HW; Guo DF; Zhang JK; Shi XY; Yu DS; Zhang XD; Wen PH; Shi JH; Zhang SJ
    Cancer Lett; 2020 Jul; 482():8-18. PubMed ID: 32278815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
    Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
    Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.